Gameel Tarek A, Tawfik Ahmad M, Abou-Farha Mohamed O, Bastawisy Mohamed G, El-Bendary Mohamed A, El-Gamasy Abd El-Naser
Urology Department, Tanta University Hospitals, Tanta, Egypt.
Arab J Urol. 2013 Dec;11(4):392-7. doi: 10.1016/j.aju.2013.05.003. Epub 2013 Jun 29.
To compare the clinical efficacy of the on-demand use of four drugs in the management of patients with premature ejaculation (PE), as the off-label use of selective serotonin-reuptake inhibitors and topical penile anaesthetics is frequently indicated for the management of patients with PE, and tramadol HCl and sildenafil citrate were also tried for managing this disorder, but with recommendations based on weak evidence.
This was a single-centre, single-blind, placebo-controlled clinical trial conducted on 150 patients who had PE for >1 year. Patients were randomised equally into five groups. On-demand tramadol, sildenafil, paroxetine, local lidocaine gel or placebo was given for patients in groups 1-5, respectively. During the month before treatment, the intravaginal ejaculation latency time (IELT) and sexual satisfaction scores (on a 0-5-point scale) were measured and compared to the mean IELT and sexual satisfaction scores recorded during 4 weeks of on-demand drug administration, with monitoring of any possible side-effects.
Tramadol-treated patients had a significantly longer mean (SD) IELT, of 351 (119) s, than the other groups. Local anaesthetic was significantly better than paroxetine in prolonging the IELT, at 278 (111) vs. 186 (65) s, respectively. The improvement in sexual satisfaction was significantly better in the sildenafil group, with a mean (SD) improvement of 2.9 (1) points, than in the paroxetine and local anaesthetic groups, at 2.2 (0.9) and 1.9 (0.9) points, respectively.
The four drugs significantly improved IELT values over placebo. Tramadol was associated with significantly longer IELT values, whilst sildenafil induced significantly better sexual satisfaction than the other drugs. The four drugs had tolerable side-effects.
比较四种按需使用药物治疗早泄(PE)患者的临床疗效,因为选择性5-羟色胺再摄取抑制剂和阴茎局部麻醉剂的非标签使用常用于治疗PE患者,盐酸曲马多和枸橼酸西地那非也曾用于治疗该疾病,但相关推荐证据不足。
这是一项单中心、单盲、安慰剂对照的临床试验,研究对象为150例患有PE超过1年的患者。患者被平均随机分为五组。第1 - 5组患者分别按需给予曲马多、西地那非、帕罗西汀、局部利多卡因凝胶或安慰剂。在治疗前一个月,测量阴道内射精潜伏期(IELT)和性满意度评分(0 - 5分制),并与按需给药4周期间记录的平均IELT和性满意度评分进行比较,同时监测任何可能的副作用。
曲马多治疗组患者的平均(标准差)IELT显著长于其他组,为351(119)秒。局部麻醉剂在延长IELT方面显著优于帕罗西汀,分别为278(111)秒和186(65)秒。西地那非组的性满意度改善显著优于帕罗西汀组和局部麻醉剂组,平均(标准差)改善分别为2.9(1)分、2.2(0.9)分和1.9(0.9)分。
这四种药物在改善IELT值方面均显著优于安慰剂。曲马多可使IELT值显著延长,而西地那非在性满意度方面的改善显著优于其他药物。这四种药物的副作用均可耐受。